Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CLE7 homolog Antibody (OTI2A4), Novus Biologicals™
SDP

Catalog No. NBP246591 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP246591 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP246591 Supplier Novus Biologicals Supplier No. NBP246591
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

Ensure accurate, reproducible results in Western Blot, Immunohistochemistry

CLE7 homolog Monoclonal specifically detects CLE7 homolog in Human samples. It is validated for Western Blot, Immunohistochemistry.

Specifications

Antigen CLE7 homolog
Applications Western Blot, Immunohistochemistry
Classification Monoclonal
Clone OTI2A4
Concentration 1 mg/mL
Conjugate Unconjugated
Dilution Western Blot 1:2000, Immunohistochemistry 1:150
Formulation PBS (pH 7.3), 1.0% BSA and 50% Glycerol with 0.02% Sodium Azide
Gene Alias CGI99, CGI-99, CLE, LCRP369, RLLM1
Gene Symbols RTRAF
Host Species Mouse
Immunogen Full length human recombinant protein of human C14orf166 (NP_057123) produced in E.coli.
Purification Method Immunogen affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 51637
Target Species Human
Content And Storage Store at -20C. Avoid freeze-thaw cycles.
Form Purified
Isotype IgG1
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.